drug protocol number

SCT22R/009

drug sponsor

King Abdullah International Medical Research Center (KAIMRC)

drug study

Hydrocortisone

drug trial site

King Abdulaziz Medical City NG (Riyadh)

drug status

Ongoing

drug phase